Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1999;84:1302-1309

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsushima, R. G.
Right arrow Articles by Backx, P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsushima, R. G.
Right arrow Articles by Backx, P. H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*IRON
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Calcium cycling/excitation-contraction coupling
Right arrow Heart failure - basic studies
(Circulation Research. 1999;84:1302-1309.)
© 1999 American Heart Association, Inc.


Original Contributions

Modulation of Iron Uptake in Heart by L-Type Ca2+ Channel Modifiers

Possible Implications in Iron Overload

Robert G. Tsushima, Alan D. Wickenden, Ron A. Bouchard, Gavin Y. Oudit, Peter P. Liu, Peter H. Backx

From the Departments of Physiology and Medicine, University of Toronto and The Toronto Hospital, Toronto, Ontario, Canada.

Correspondence to Dr Peter H. Backx, Department of Medicine, The Toronto Hospital, CCRW 3-802, 101 College St, Toronto, Ontario M5G 2C4, Canada. E-mail p.backx{at}utoronto.ca

Abstract—Heart failure is the leading cause of mortality in patients with transfusional iron (Fe) overload in which myocardial iron uptake ensues via a transferrin-independent process. We examined the ability of L-type Ca2+ channel modifiers to alter Fe2+ uptake by isolated rat hearts and ventricular myocytes. Perfusion of rat hearts with 100 nmol/L 59Fe2+ and 5 mmol/L ascorbate resulted in specific 59Fe2+ uptake of 20.4±1.9 ng of Fe per gram dry wt. Abolishing myocardial electrical excitability with 20 mmol/L KCl reduced specific 59Fe2+ uptake by 60±7% (P<0.01), which suggested that a component of myocardial Fe2+ uptake depends on membrane voltage. Accordingly, 59Fe2+ uptake was inhibited by 10 µmol/L nifedipine (45±12%, P<0.02) and 100 µmol/L Cd2+ (86±3%; P<0.001) while being augmented by 100 nmol/L Bay K 8644 (61±18%, P<0.01) or 100 nmol/L isoproterenol (40±12%, P<0.05). By contrast, uptake of 100 nmol/L ferric iron (59Fe3+) was significantly lower (1.4±0.3 ng Fe per gram dry wt; P<0.001) compared with divalent iron. These data suggest that a component of Fe2+ uptake into heart occurs via the L-type Ca2+ channel in myocytes. To investigate this further, the effects of Fe2+ on cardiac myocyte L-type Ca2+ currents were measured. In the absence of Ca2+, noninactivating nitrendipine-sensitive Fe2+ currents were recorded with 15 mmol/L [Fe2+]o. Low concentrations of Fe2+ enhanced Ca2+ current amplitude and slowed inactivation rates, which was consistent with Fe2+ entry into the cell, whereas higher Fe2+ levels caused dose-dependent decreases in peak current. Fe3+ had no effect on current amplitude or decay. Combined, our data suggest that myocardial Fe2+ uptake occurs via L-type Ca2+ channels and that blockade of these channels might be useful in the treatment of patients with excessive serum iron levels.


Key Words: iron overload • channels • heart failure • permeability • Ca2+




This article has been cited by other articles:


Home page
BloodHome page
H. Glickstein, R. B. El, G. Link, W. Breuer, A. M. Konijn, C. Hershko, H. Nick, and Z. I. Cabantchik
Action of chelators in iron-loaded cardiac cells: accessibility to intracellular labile iron and functional consequences
Blood, November 1, 2006; 108(9): 3195 - 3203.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. A. Heilig, K. J. Thompson, R. M. Molina, A. R. Ivanov, J. D. Brain, and M. Wessling-Resnick
Manganese and iron transport across pulmonary epithelium
Am J Physiol Lung Cell Mol Physiol, June 1, 2006; 290(6): L1247 - L1259.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
A. Donovan, C. N. Roy, and N. C. Andrews
The Ins and Outs of Iron Homeostasis
Physiology, April 1, 2006; 21(2): 115 - 123.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Y. Oudit, M. G. Trivieri, N. Khaper, T. Husain, G. J. Wilson, P. Liu, M. J. Sole, and P. H. Backx
Taurine Supplementation Reduces Oxidative Stress and Improves Cardiovascular Function in an Iron-Overload Murine Model
Circulation, April 20, 2004; 109(15): 1877 - 1885.
[Abstract] [Full Text] [PDF]